文档介绍：尼莫地平防治蛛网膜下腔出血后脑血管痉挛疗效观察
【摘要】目的探讨尼莫地平防治蛛网膜下隙出血后脑血管痉挛的疗效。方法将70例蛛网膜下腔出血后脑血管痉挛的患者随机分为尼莫地平组(观察组)和对照组,对照组用脱水、止血等常规疗法,观察组在常规疗法基础上加用尼莫地平。结果尼莫地平组防治蛛网膜下腔出血后脑血管痉挛疗效优于对照组,2组疗效比较差异有统计学意义(P<) 。结论尼莫地平防治蛛网膜下隙出血后脑血管痉挛安全有效。
【关键词】尼莫地平;蛛网膜下隙出血;脑血管痉挛
Objective To observe the clinical effects of nimodipine on vascular spasm followed by subarachnoid Seventy patients with cerebral vasospasm after subarachnoid hemorrhage were randomly divided into nimodipine group (observation group) and control group, control group was given dehydration, bleeding and other conventional therapies, and observation group was added nimodipine on the basis of conventional therapy. Results The effect of prevention and treatment of cerebral vasospasm after subarachnoid hemorrhage in nimodipine group was more effective than that of control group, the difference between the two groups was significant (P<). Conclusion Nimodipine treating subarachnoid hemorrhage cerebral vasospasm is safe and effe
ctive.

【Key words】 Nimodipine; Subarachnoid hemorrhage; Cerebral vasospasm

脑血管痉挛(CVS)是蛛网膜下腔出血(SAH)的严重并发症之一,是SAH致死、致残的主要原因。%~%,是SAH患者病残和死亡的主要原因,SAH发生后防治CVS的发生有着重要的临床意义[1]。200610~200908选择我们收治的蛛网膜下腔出血并发脑血管痉挛的患者70例,随机分为尼莫地平组和对照组,取得满意效果,现总结知下。
1 资料与方法
一般资料选择70例SAH病人,均经腰穿和(或)CT确诊,均于发病72h内入院接受治疗。按入院时间先后顺序随机分为尼莫地平组(观察组)和对照组各35例。尼莫地平组男20例,女15例,年龄(54±6)岁;伴动眼神经麻痹2例,高血压史6例。对